Gene Query: ODF2L

Dataset Description Geneva Score
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 85.27
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 45.85
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 32.84
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 25.38
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 25.09
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 23.82
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 23.67
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 22.63
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 22.38
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 19.74
NRDE2 negatively regulates nuclear exosome functions 19.53
Reassessment of Exosome Composition 19.4
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 19.0
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 18.82
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 18.72
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 18.45
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 18.3
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 18.13
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 17.92
Human cell line and subcutaneous tumor 17.88
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 17.85
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 17.79
Gene expression profile of human iPSC-derived nephron progenitor cells 17.16
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 16.83
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 16.27
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 15.91
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 15.42
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 15.42
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 15.41
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 15.06
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 14.99
Microprocessor mediates transcription termination in long noncoding microRNA genes 14.79
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 14.77
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 14.59
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 13.94
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 13.94
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 13.94
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 13.89
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 13.89
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 13.85
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 13.85
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 13.73
Unique features and clinical importance of acute alloreactive immune responses 13.22
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 13.06
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 12.81
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 12.71
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 12.62
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 12.38
An RNA-centric dissection of host complexes controlling flavivirus infection 12.38
RNA expression following TMPRSS11B overexpression or depletion 12.21
Exploring the RNA landscape of endothelial exosomes 12.12
High-throughput sequencing of PROMPT-enriched samples. 12.04
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 12.01
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 11.97
IRF2 is a master regulator of human keratinocyte stem cell fate 11.76
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 11.76
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 11.71
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 11.65
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 11.53
RNA m5C Methylation in breast cancer using MeRIP-Seq 11.45
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 11.41
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 11.19
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 11.16
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 11.11
Global Mapping of Human RNA-RNA Interactions 11.1
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 11.02
Transcriptome analysis of human lung epithelial cells 10.84
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 10.74
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 10.66
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 10.65
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 10.45
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 10.4
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 10.34
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 10.3
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 10.28
Single-Cell Genotyping of Transcriptomes 10.25
RNA-seq of Single-Cell Genotyping of Transcriptomes 10.25
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 10.25
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 10.25
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 10.21
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 10.2
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 10.12
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 10.1
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 10.1
Aortic Valve Tissue: Stenosis vs. Sclerosis 10.04
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 10.03
RNA-seq of resting and activated CD4+ T cells +-JQ1 10.02
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 9.96
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 9.88
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 9.66
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 9.52
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 9.43
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 9.42
HNF1A deficiency impairs β-cell fate, granule maturation and function 9.17
MicroRNA-125a-5p overexpression in human macrophages 9.12
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 9.11
TOP2B disturbed the quality of human oocytes with advanced maternal age 9.09
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 8.94
Oncogenic MYC induces a dependency on the spliceosome in human cancer 8.89
Targeted enhancer activation by a subunit of the integrator complex 8.84
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 8.7
CROP-Seq in Primary Human T Cells 8.7
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 8.68
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 8.67
The age and genomic integrity of neurons after cortical stroke in humans 8.64
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 8.64
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 8.6
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 8.6
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 8.53
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 8.53
T47D RNA-seq and ChrRNA-seq data 8.48
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 8.48
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 8.48
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 8.44
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 8.43
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 8.33
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 8.27
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 8.26
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 8.23
Transcriptional landscape changes during human embryonic stem cell derivation 8.17
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 8.16
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 8.16
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 8.13
CircRNAome diversity in human mature B-cells, T-cells and monocytes 8.1
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 8.05
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 8.02
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 7.89
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 7.85
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 7.84
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 7.78
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 7.67
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 7.63
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 7.62
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 7.56
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 7.54
RNA-sequencing of human tendon after injury 7.53
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 7.5
HEK293 Heat-shock experiment 7.44
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 7.43
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 7.42
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 7.41
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 7.39
Capturing the Interactome of Newly Transcribed RNA 7.36
Capturing the Interactome of Newly Transcribed RNA (RICK) 7.36
Hypoxic transcriptome of SQ20B human head and neck cancer cells 7.36
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 7.36
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 7.32
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 7.32
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 7.31
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 7.3
7.3
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 7.29
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 7.19
Electronic cigarettes 7.18
RNA polymerase in pre-B-ALL cell lines 7.17
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 7.15
Dynamic 3D chromosomal landscapes in acute leukemia 7.14
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 7.14
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 7.11
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 7.1
Transcription elongation regulates genome 3D structure 7.08
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 7.03
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 7.03
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 6.93
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 6.85
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 6.83
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 6.79
TCF7L1 knockdown in pancreatic cancer 6.78
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 6.77
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 6.74
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 6.69
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 6.69
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 6.68
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 6.67
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 6.61
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 6.57
Transcriptome analysis of H9 hESC derived cerebral organoids 6.56
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 6.55
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 6.51
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 6.47
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 6.43
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 6.43
RNA-seq analysis of breast cancer 6.38
RNA-seq analysis and shRNA screen of breast cancer 6.38
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 6.37
mRNA expression profile of Lymphocytes 6.34
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 6.34
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 6.34
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 6.33
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 6.32
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 6.32
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 6.27
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 6.27
Uridylation by TUT4 and TUT7 marks mRNA for degradation 6.26
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 6.26
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 6.24
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 6.24
mRNA-Seq profiling of human developing kidney 6.2
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 6.2
Transciptomic profiling of human fetal lung samples 6.17
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 6.15
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 6.14
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 6.13
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 6.11
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 6.11
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 6.07
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 6.05
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 6.03
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 6.02
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 6.01
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 5.98
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 5.92
ARID1A regulates condensin II distribution and chromosomal partition 5.92
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 5.91
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 5.9
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 5.9
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 5.84
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 5.84
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 5.84
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 5.73
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 5.73
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 5.71
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 5.69
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 5.66
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 5.65
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 5.65
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 5.62
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 5.57
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 5.57
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 5.51
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 5.48
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 5.48
Human Treg IL-12 stimulation 5.47
MYC dependent mRNA translation shapes gene expression and cell biology 5.47
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 5.4
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 5.31
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 5.28
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 5.24
RNA editing in nascent RNA affects pre-mRNA splicing 5.24
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 5.2
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 5.2
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 5.08
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 5.0
Regulation of poly(A) tail and translation during the somatic cell cycle 4.95
MRTF activates TEAD-YAP target gene expression 4.94
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 4.89
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 4.88
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 4.88
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 4.88
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 4.86
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 4.85
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 4.83
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 4.81
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 4.81
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 4.77
Common inflammatory pathways between NEC and Crohn's disease 4.71
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 4.64
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 4.6
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 4.57
4sUDRB-seq: measuring transcription elongation and initiation genomewide 4.55
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 4.51
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 4.51
Clinker: visualizing fusion genes detected in RNA-seq data 4.47
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 4.44
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 4.4
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 4.39
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 4.34
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 4.34
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 4.32
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 4.3
Metastasis in triple-negative breast cancer 4.3
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 4.23
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 4.22
naive T cell heterogeneity after neonatal thymectomy 4.2
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 4.18
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 4.07
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 4.07
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 4.07
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 4.06
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 4.06
Endothelial gene expression analysis 4.06
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 4.05
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 4.04
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 4.01
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 3.99
RNA-Seq in neutrophils from Antiphospholipid Syndrome 3.99
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 3.98
quanTIseq: quantifying immune contexture of human tumors 3.97
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 3.92
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 3.91
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 3.89
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 3.87
CD73 knockdown effect in pancreatic cancer cell lines 3.84
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 3.77
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 3.77
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 3.77
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 3.74
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 3.73
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 3.64
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 3.64
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 3.6
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 3.59
Human neutrophil genome during PMA- and E. coli encounter-induced activation 3.58
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 3.58
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 3.57
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 3.56
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 3.5
RNA-seq melanoma 3.5
6mer seed toxicity in tumour suppressive microRNAs 3.48
Gene expression profile in breast cancer cell lines using RNA sequencing 3.45
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 3.42
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 3.35
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 3.34
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 3.34
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 3.34
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 3.33
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 3.33
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 3.32
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 3.3
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 3.3
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 3.25
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 3.18
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 3.17
RNA-seq data 3.15
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 3.12
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 3.12
Transcriptome analysis reveals differential splicing events in IPF lung tissue 3.11
Gene expression analysis of human hepatocellular cancers 3.09
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 3.06
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 3.05
HEXIM1 is induced by DHODH inhibition to suppress melanoma 3.05
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 3.05
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 2.97
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 2.97
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 2.97
Gene expression activation in CLL mediated by MSCs contact 2.96
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 2.91
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 2.85
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 2.84
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 2.84
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 2.82
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 2.82
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 2.77
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 2.77
Studying the selectivity of a small molecule Synucleozid on transcriptome 2.76
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 2.75
Changes in human endometrial gland transcriptome over the window of implantation 2.69
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 2.68
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 2.67
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 2.66
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 2.65
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 2.54
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 2.51
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 2.51
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 2.49
Transcriptome landscape of HeLa response upon triamcinolone acetonide 2.46
RNA-seq analysis of control and Myc-induced U2OS cells 2.45
Polarized B -cell functions 2.42
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 2.4
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 2.37
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 2.35
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 2.31
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 2.31
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 2.3
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 2.3
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 2.27
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 2.25
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 2.25
Entrectinib Resistance in a Neuroblastoma Xenograft Model 2.22
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 2.18
Effect of BB608 on Gene Expression in HNSCC Cell Line 2.17
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 2.15
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 2.12
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 2.05
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 2.05
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 2.03
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 2.03
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 2.0
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.99
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 1.97
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 1.94
The chromatin modifier CHD8 targets autism risk genes during human neurodevelopment  1.93
mRNA recovered upon RNF219 IP. [RNA-IP] 1.92
The contribution of Alu exons to the human proteome 1.86
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 1.85
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 1.84
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 1.83
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 1.83
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 1.83
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.8
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 1.78
Determination of tRNA aminoacylation levels by high throughput sequencing 1.77
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 1.76
mRNA-sequencing of breast cancer subtypes and normal tissue 1.71
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 1.7
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.67
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 1.65
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 1.62
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 1.6
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 1.59
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 1.58
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.58
CDK4/6 inhibitor resistance in prostate cancer 1.57
Gene expression analysis of human adenomas. 1.54
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  1.53
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 1.53
RNA seq comparison between scrambled and shGRP78 cells 1.5
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 1.48
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 1.48
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 1.47
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 1.4
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 1.4
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 1.4
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 1.38
JunB control of keratinocyte-mediated inflammation [RNA-seq] 1.38
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 1.33
Myc activation coordinates gene transcription and protein translation responses 1.33
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 1.3
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 1.29
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 1.27
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 1.25
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 1.25
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 1.25
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 1.24
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 1.22
Transcriptome profiling of A2M treated A549 Cell Line Samples 1.22
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 1.2
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 1.2
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 1.2
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 1.2
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 1.2
The role of CFTR in islet function 1.18
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 1.18
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 1.18
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 1.09
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 1.08
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 1.06
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 1.06
Zika virus directly infects human peripheral neurons and induces cell death 1.03
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 1.02
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 1.02
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.89
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 0.89
RNA-seq of SCLC PDX models treated with EP 0.86
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.85
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 0.85
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 0.84
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 0.84
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 0.84
Transcriptomic profiling of human peripheral blood-derived mast cells 0.84
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.84
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 0.83
Triple vectors expand AAV transfer capacity in the retina 0.82
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 0.82
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.8
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 0.79
HBEC-shp53-PCHD7 0.78
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.77
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 0.72
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.69
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.69
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.68
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 0.65
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.64
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 0.58
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 0.58
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.57
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 0.56
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 0.56
Human T-cell lymphoblastic lymphoma samples and control thymuses 0.54
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 0.54
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 0.53
Human Tfh cell RNA bulk sequencing 0.51
Transcriptome-wide response to synthetic chromatin protein PcTF 0.51
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.5
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 0.47
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.45
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 0.44
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 0.43
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.4
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 0.4
Aging-associated patterns in the expression of human endogenous retroviruses 0.4
A single-cell transcriptome atlas of the human pancreas 0.38
Transcriptome of activated human and mouse MAIT cells 0.33
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 0.28
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 0.27
SNHG5 siRNA knock down in HCT116 cells 0.24
Global transcriptome analysis of WT versus HEB-/- hESCs 0.18
Enhancer activation during EGF response 0.17
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.14
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.14
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.13
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 0.13
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 0.13
Interphase condensins regulate ligand-depedent enhancer activation 0.1
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.1
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 0.08
nELAVL HITS-CLIP in Alzheimer's Disease patients 0.08
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.02
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation